Related Experiment Video
Updated: Jun 4, 2025

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Detection of carcinoembryonic antigen using aggregation-induced emission luminogens empowered triple-format biosensor
Yongfeng Lu1, Caihong Liu2, Yanling Liu3
1Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital Chengdu, Sichuan 610072, China; School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610054, China.
A novel "immune-sandwich" sensor uses ultrabright aggregation-induced emission luminogens (AIEgens) for sensitive carcinoembryonic antigen (CEA) detection. This NeSCV sensor offers triple detection modes and significantly outperforms traditional methods for lung cancer diagnosis.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Nanotechnology
Background:
- Conventional fluorescent probes suffer from weak signals and aggregation-caused quenching, limiting biomarker detection sensitivity.
- Existing methods often require high concentrations of labeled target molecules to achieve adequate signal-to-noise ratios.
- There is a need for highly sensitive and reliable diagnostic tools for early cancer detection and monitoring.
Purpose of the Study:
- To develop an ultrasensitive affinity sensor for detecting carcinoembryonic antigen (CEA) using aggregation-induced emission luminogens (AIEgens).
- To enable simultaneous detection of CEA through visual, spectral, and computer vision analysis (NeSCV sensor).
- To evaluate the sensor's performance in clinical serum samples for lung cancer diagnosis.
Main Methods:
- Fabrication of an "immune-sandwich" based affinity sensor utilizing AIEgens-functionalized microspheres as signal reporters.
- Development of three distinct detection formats: naked-eye visual inspection, spectrometer-based solution analysis, and fluorescence microscopy of solid-state complexes.
- Qualitative and quantitative analysis of CEA in serum samples from lung cancer patients and healthy controls.
Main Results:
- The NeSCV sensor achieved a limit of quantification of 1 fg/mL, significantly lower than conventional methods like ELISA.
- Demonstrated high selectivity, accuracy, and sensitivity in detecting CEA across a linear range of 1 fg/mL to 10 ng/mL.
- Achieved a 90% accuracy rate in a blind test on an independent validation cohort, confirming robustness.
Conclusions:
- The developed NeSCV sensor provides a highly sensitive, selective, and versatile platform for CEA detection.
- This technology offers potential for early lung cancer identification, treatment monitoring, and personalized medicine.
- The triple detection capability enhances accessibility and applicability in diverse diagnostic settings.
More Related Videos
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020